ArticleFrontiers in medicine2022
Mortality Among Hospitalized Patients With Pleural Effusions. A Multicenter, Observational, Prospective Study.
Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 23 citations in OpenAlex.
- The Influence of COVID-19 on the Composition and Drug Resistance of Pleural Effusion in Shandong Province.MicrobiologyOpen · 2026Article
- A new diagnostic prediction model for infective endocarditis based on the 2023 duke-international society for cardiovascular infectious disease criteria: a multicenter observational study.BMC cardiovascular disorders · 2026Observational
- Integrating interventional pulmonology and thoracic surgery: a multidisciplinary approach to advanced pulmonary care.Journal of thoracic disease · 2026Review
- Hyperthermic Intrathoracic Chemotherapy and Photodynamic Therapy: A Single-Institution Experience for Malignant Pleural Diseases.Oncology · 2026Article
- Mapping heterogeneity in the management of malignant pleural effusions with indwelling pleural catheters in Denmark - a national survey.European clinical respiratory journal · 2026Article
- Long-term outcomes after pleural decortication for patients with chronic sterile, non-malignant pleural effusion.Journal of thoracic disease · 2025Article
- Non-Specific Pleuritis After Medical Thoracoscopy: The Portrait of an Open Issue and Practical Hints for Its Management.Biomedicines · 2025Article
- Predictors of successful closure following open-window thoracostomy in patients with empyema: a single-center retrospective cohort study.Journal of thoracic disease · 2025Article
- Article
- Sarcopenia and Pleural Effusions: Exploring a Potential Link.Muscles (Basel, Switzerland) · 2024Review
- Infective Pleural Effusions-A Comprehensive Narrative Review Article.Clinics and practice · 2024Review
- Acute kidney injury in hospitalized patients with nonmalignant pleural effusions: a retrospective cohort study.BMC nephrology · 2024Article
- Pleural Effusion Identified by Point of Care Ultrasound (POCUS) in Septic Shock: Impact on Clinical Outcomes.POCUS journal · 2024Article
- Pleural effusion portends a poor prognosis in patients on continuous ambulatory peritoneal dialysis.PloS one · 2024Article
- Chest wall reconstruction after the Clagett procedure and other types of open-window thoracostomy: a narrative review.Journal of thoracic disease · 2023Review
- Clinical characteristics of chylothorax: results from the International Collaborative Effusion database.ERJ open research · 2023Article
- Assessment of non-tuberculosis abnormalities on digital chest x-rays with high CAD4TB scores from a tuberculosis prevalence survey in Zambia and South Africa.BMC infectious diseases · 2023Article
- ESBL and carbapenemase-producing Enterobacteriaceae in infectious pleural effusions: current epidemiology at Hôpital du Mali.Drug target insightsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Data regarding the prognostic significance of pleural effusion (PE) are scarce. Objective: Explore the impact of PE on mortality among hospitalized patients. Methods: Multicenter prospective observational study. Patients that underwent computed tomography (thorax and/or abdomen) and in which PE was detected, were admitted to the study. PE was classified by size on CT, anatomical distribution, diagnosis, and Light's criteria. Charlson comorbidity index (CCI), APACHE II, and SOFA score were calculated. Mortality at 1 month and 1 year were recorded. Results: Five hundred and eight subjects, mean age 78 years. Overall mortality was 22.6% at 1 month and 49.4% at 1 year. Bilateral effusions were associated with higher mortality than unilateral effusions at 1 month (32 vs. 13.3%, Conclusions: Pleural effusion is a marker of advanced disease. Mortality is higher within the first month in patients with PEs related to organ failure, while patients with MPE have the worst long-term outcome. Independent predictors of mortality, apart from CCI, APACHE II, and SOFA scores, are age and bilateral distribution in the short-term, and malignancy in the long-term.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.